Roberto Fogari

Summary

Affiliation: University of Pavia
Country: Italy

Publications

  1. ncbi Effects of manidipine/delapril versus olmesartan/hydrochlorothiazide combination therapy in elderly hypertensive patients with type 2 diabetes mellitus
    Roberto Fogari
    Department of Internal Medicine and Therapeutics, Clinica Medica II Fondazione IRCCS Policlinico S Matteo, University of Pavia, Italy
    Hypertens Res 31:43-50. 2008
  2. ncbi Prevalence of primary aldosteronism among unselected hypertensive patients: a prospective study based on the use of an aldosterone/renin ratio above 25 as a screening test
    Roberto Fogari
    Department of Internal Medicine and Therapeutics, Clinica Medica II IRCCS Policlinico S Matteo, University of Pavia, Italy
    Hypertens Res 30:111-7. 2007
  3. ncbi Effects of valsartan compared with enalapril on blood pressure and cognitive function in elderly patients with essential hypertension
    Roberto Fogari
    Department of Internal Medicine and Therapeutics, Centro Ipertensione e Fisiopatologia Cardiovascolare, Clinica Medica II, IRCCS Policlinico S Matteo, University of Pavia, Piazzale Golgi 2, 27100, Pavia, Italy
    Eur J Clin Pharmacol 59:863-8. 2004
  4. ncbi Effect of antihypertensive agents on quality of life in the elderly
    Roberto Fogari
    Department of Internal Medicine and Therapeutics, Clinica Medica II, IRCCS Policlinico S Matteo, University of Pavia, Pavia, Italy
    Drugs Aging 21:377-93. 2004
  5. ncbi Effects of amlodipine-atorvastatin combination on inflammation markers and insulin sensitivity in normocholesterolemic obese hypertensive patients
    Roberto Fogari
    Department of Internal Medicine and Therapeutics, Clinica Medica II, IRCCS Policlinico S Matteo, University of Pavia, Piazzale Golgi 19, 27100, Pavia, Italy
    Eur J Clin Pharmacol 62:817-22. 2006
  6. ncbi Effect of telmisartan/hydrochlorothiazide combination versus nifedipine GITS on ambulatory blood pressure and sympathetic activation
    Roberto Fogari
    Department of Internal Medicine and Therapeutics, Clinica Medica II IRCCS Policlinico S Matteo, University of Pavia, Pavia, Italy
    Am J Hypertens 18:577-83. 2005
  7. ncbi Is the effect of antihypertensive drugs on platelet aggregability and fibrinolysis clinically relevant?
    Roberto Fogari
    Department of Internal Medicine and Therapeutics, Clinica Medica II, I R C C S Policlinico San Matteo, University of Pavia, Pavia, Italy
    Am J Cardiovasc Drugs 5:211-23. 2005
  8. ncbi Effect of successful hypertension control by manidipine or lisinopril on albuminuria and left ventricular mass in diabetic hypertensive patients with microalbuminuria
    Roberto Fogari
    Department of Internal Medicine and Therapeutics, Clinica Medica II, University of Pavia, IRCCS Policlinico S Matteo, 27100, Pavia, Italy
    Eur J Clin Pharmacol 61:483-90. 2005
  9. ncbi Comparison of the effects of valsartan and felodipine on plasma leptin and insulin sensitivity in hypertensive obese patients
    Roberto Fogari
    Department of Internal Medicine and Therapeutics, IRCCS Policlinico S Matteo, University of Pavia, Pavia, Italy
    Hypertens Res 28:209-14. 2005
  10. ncbi Effect of telmisartan/hydrochlorothiazide vs lisinopril/hydrochlorothiazide combination on ambulatory blood pressure and cognitive function in elderly hypertensive patients
    R Fogari
    Department of Internal Medicine and Therapeutics, Clinica Medica II, IRCCS Policlinico S Matteo, University of Pavia, Pavia, Italy
    J Hum Hypertens 20:177-85. 2006

Collaborators

Detail Information

Publications81

  1. ncbi Effects of manidipine/delapril versus olmesartan/hydrochlorothiazide combination therapy in elderly hypertensive patients with type 2 diabetes mellitus
    Roberto Fogari
    Department of Internal Medicine and Therapeutics, Clinica Medica II Fondazione IRCCS Policlinico S Matteo, University of Pavia, Italy
    Hypertens Res 31:43-50. 2008
    ..However, manidipine/delapril offered some advantages in terms of the less-pronounced BP orthostatic changes and absence of metabolic adverse effects...
  2. ncbi Prevalence of primary aldosteronism among unselected hypertensive patients: a prospective study based on the use of an aldosterone/renin ratio above 25 as a screening test
    Roberto Fogari
    Department of Internal Medicine and Therapeutics, Clinica Medica II IRCCS Policlinico S Matteo, University of Pavia, Italy
    Hypertens Res 30:111-7. 2007
    ..9% of the studied population), most of whom are normokalemic. Bilateral adrenal hypertrophy represents the more common form of PA...
  3. ncbi Effects of valsartan compared with enalapril on blood pressure and cognitive function in elderly patients with essential hypertension
    Roberto Fogari
    Department of Internal Medicine and Therapeutics, Centro Ipertensione e Fisiopatologia Cardiovascolare, Clinica Medica II, IRCCS Policlinico S Matteo, University of Pavia, Piazzale Golgi 2, 27100, Pavia, Italy
    Eur J Clin Pharmacol 59:863-8. 2004
    ....
  4. ncbi Effect of antihypertensive agents on quality of life in the elderly
    Roberto Fogari
    Department of Internal Medicine and Therapeutics, Clinica Medica II, IRCCS Policlinico S Matteo, University of Pavia, Pavia, Italy
    Drugs Aging 21:377-93. 2004
    ....
  5. ncbi Effects of amlodipine-atorvastatin combination on inflammation markers and insulin sensitivity in normocholesterolemic obese hypertensive patients
    Roberto Fogari
    Department of Internal Medicine and Therapeutics, Clinica Medica II, IRCCS Policlinico S Matteo, University of Pavia, Piazzale Golgi 19, 27100, Pavia, Italy
    Eur J Clin Pharmacol 62:817-22. 2006
    ..The objective of this study was to assess the effect of amlodipine-atorvastatin combination on plasma interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha) and insulin sensitivity in normocholesterolemic obese hypertensive patients...
  6. ncbi Effect of telmisartan/hydrochlorothiazide combination versus nifedipine GITS on ambulatory blood pressure and sympathetic activation
    Roberto Fogari
    Department of Internal Medicine and Therapeutics, Clinica Medica II IRCCS Policlinico S Matteo, University of Pavia, Pavia, Italy
    Am J Hypertens 18:577-83. 2005
    ..This study compares the effects of telmisartan hydrochlorothiazide (HCTZ) combination versus nifedipine GITS on ambulatory blood pressure (BP) and sympathetic activity, in patients with mild-to-moderate hypertension...
  7. ncbi Is the effect of antihypertensive drugs on platelet aggregability and fibrinolysis clinically relevant?
    Roberto Fogari
    Department of Internal Medicine and Therapeutics, Clinica Medica II, I R C C S Policlinico San Matteo, University of Pavia, Pavia, Italy
    Am J Cardiovasc Drugs 5:211-23. 2005
    ..Selected agents should have a favorable, or at least neutral, impact on fibrinolytic function and platelet activity...
  8. ncbi Effect of successful hypertension control by manidipine or lisinopril on albuminuria and left ventricular mass in diabetic hypertensive patients with microalbuminuria
    Roberto Fogari
    Department of Internal Medicine and Therapeutics, Clinica Medica II, University of Pavia, IRCCS Policlinico S Matteo, 27100, Pavia, Italy
    Eur J Clin Pharmacol 61:483-90. 2005
    ....
  9. ncbi Comparison of the effects of valsartan and felodipine on plasma leptin and insulin sensitivity in hypertensive obese patients
    Roberto Fogari
    Department of Internal Medicine and Therapeutics, IRCCS Policlinico S Matteo, University of Pavia, Pavia, Italy
    Hypertens Res 28:209-14. 2005
    ..These results suggest that in hypertensive obese subjects, treatment with valsartan might offer an advantage over treatment with felodipine, since valsartan may help to improve obesity-related disorders in addition to lowering BP...
  10. ncbi Effect of telmisartan/hydrochlorothiazide vs lisinopril/hydrochlorothiazide combination on ambulatory blood pressure and cognitive function in elderly hypertensive patients
    R Fogari
    Department of Internal Medicine and Therapeutics, Clinica Medica II, IRCCS Policlinico S Matteo, University of Pavia, Pavia, Italy
    J Hum Hypertens 20:177-85. 2006
    ....
  11. ncbi Serum testosterone levels and arterial blood pressure in the elderly
    Roberto Fogari
    Department of Internal Medicine and Therapeutic, Clinica Medica 11, IRCCS Policlinico S Matteo, University of Pavia, Pavia, Italy
    Hypertens Res 28:625-30. 2005
    ....
  12. ncbi Ankle oedema and sympathetic activation
    Roberto Fogari
    Department of Internal Medicine, University of Pavia, Pavia, Italy
    Drugs 65:21-7. 2005
    ....
  13. ncbi Effect on the development of ankle edema of adding delapril to manidipine in patients with mild to moderate essential hypertension: a three-way crossover study
    Roberto Fogari
    Dipartimento di Medicina Interna, Clinica Medica, IRCCS Policlinico S Matteo, Universita di Pavia, Pavia, Italy
    Clin Ther 29:413-8. 2007
    ..In particular, such combinations have been found to reduce the incidence of ankle edema, the most common adverse effect of dihydropyridine annhypertensives...
  14. ncbi Antihypertensive drugs and fibrinolytic function
    Roberto Fogari
    Department of Internal Medicine, University of Pavia, Clinica Medica II, IRCCS Policlinico S Matteo, Pavia, Italy
    Am J Hypertens 19:1293-9. 2006
    ..The greater improvement in the fibrinolytic balance because of the combined action of ACE inhibition and Ca antagonism represents a further indication to the use of combinations of ACE-I and CCB in the treatment of hypertension...
  15. ncbi Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients
    R Fogari
    Dipartimento di Medicina Interna, Clinica Medica II, IRCCS Policlinico S Matteo, Universita di Pavia, Pavia, Italy
    J Hum Hypertens 21:220-4. 2007
    ..These results suggest that angiotensin receptor blockers partially counteract the microcirculatory changes responsible for calcium channel blockers induced oedema formation...
  16. ncbi Effect of telmisartan-amlodipine combination at different doses on urinary albumin excretion in hypertensive diabetic patients with microalbuminuria
    Roberto Fogari
    Department of Internal Medicine and Therapeutics, Clinica Medica II IRCCS Policlinico S Matteo, University of Pavia, Pavia, Italy
    Am J Hypertens 20:417-22. 2007
    ..Aim of this study was to evaluate the effect of the telmisartan-amlodipine combination at different doses on urinary albumin excretion rate (UAER) in hypertensive diabetic patients with microalbuminuria...
  17. ncbi Effect of valsartan and atenolol on sexual behavior in hypertensive postmenopausal women
    Roberto Fogari
    Department of Internal Medicine, University of Pavia, Pavia, Italy
    Am J Hypertens 17:77-81. 2004
    ..The aim of this study was to evaluate the effect of valsartan compared with atenolol on sexual behavior in hypertensive postmenopausal women...
  18. ncbi Efficacy and safety of olmesartan medoxomil 40 mg/hydrochlorothiazide 12.5 mg combination therapy versus olmesartan medoxomil 40 mg monotherapy in patients with moderate to severe hypertension: a randomized, double-blind, parallel-group, multicentre, mult
    Roberto Fogari
    Medical Clinic II Policlinic San Matteo, University of Pavia, Pavia, Italy
    Clin Drug Investig 30:581-97. 2010
    ..Current hypertension guidelines recommend using two antihypertensive agents when blood pressure (BP) control is not achieved with one single agent...
  19. ncbi Losartan and prevention of atrial fibrillation recurrence in hypertensive patients
    Roberto Fogari
    Department of Internal Medicine and Therapeuthics, Clinica Medica II, IRCCS Policlinico S Matteo, University of Pavia, Pavia, Italy
    J Cardiovasc Pharmacol 47:46-50. 2006
    ..This might be related to possible favorable impact of angiotensin II receptor blockers (ARB) on the atrial electrical and structural remodeling in this type of patients...
  20. ncbi Combination delapril/manidipine as antihypertensive therapy in high-risk patients
    Roberto Fogari
    Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy
    Clin Drug Investig 31:439-53. 2011
    ....
  21. ncbi Differential effects of lercanidipine and nifedipine GITS on plasma norepinephrine in chronic treatment of hypertension
    Roberto Fogari
    Centro Ipertensione e Fisiopatologia Cardiovascolare, Dipartimento di Medicina Interna e Terapia Medica, Clinica Medica II Università di Pavia, Pavia, Italy
    Am J Hypertens 16:596-9. 2003
    ....
  22. ncbi Effect of benazepril addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients
    R Fogari
    Dipartimento di Medicina Interna, Clinica Medica, IRCCS Policlinico S Matteo, Universita di Pavia, Pavia, Italy
    J Hum Hypertens 17:207-12. 2003
    ..These results suggest that ACE-inhibitors partially counteract the microcirculatory changes responsible for Ca-antagonists-induced oedema formation...
  23. ncbi Effects of amlodipine fosinopril combination on microalbuminuria in hypertensive type 2 diabetic patients
    Roberto Fogari
    Department of Internal Medicine and Therapeutics, Clinica Medica IRCCS Policlinico S Matteo, University of Pavia, Pavia, Italy
    Am J Hypertens 15:1042-9. 2002
    ..The aim of this study is to compare the long-term effect of amlodipine and fosinopril in monotherapy or in combination on urinary albumin excretion (UAE) in hypertensive diabetic patients...
  24. ncbi Effect of antihypertensive treatment with valsartan or atenolol on sexual activity and plasma testosterone in hypertensive men
    Roberto Fogari
    Department of Internal Medicine and Therapeutics, Clinica Medica IRCCS Policlinico S Matteo, University of Pavia, Piazzale Golgi 2, 27100 Pavia, Italy
    Eur J Clin Pharmacol 58:177-80. 2002
    ..To compare the effects of valsartan and atenolol on sexual activity and plasma testosterone in newly diagnosed, previously untreated, essential hypertensive male subjects...
  25. ncbi Effect of indomethacin on the antihypertensive efficacy of valsartan and lisinopril: a multicentre study
    Roberto Fogari
    Dipartimento di Medicina Interna, IRCCS Policlinico S Matteo, Universita di Pavia, Pavia, Italy
    J Hypertens 20:1007-14. 2002
    ....
  26. ncbi Effects of antihypertensive therapy on sexual activity in hypertensive men
    Roberto Fogari
    Clinica Medica II, IRCCS Policlinico S Matteo, Piazzale Golgi, 2, 27100 Pavia, Italy
    Curr Hypertens Rep 4:202-10. 2002
    ..This ensures the best balance between therapeutic efficacy and quality of life, which is essential for compliance...
  27. ncbi Effect of benazepril amlodipine combination on fibrinolysis in hypertensive diabetic patients
    Roberto Fogari
    Department of Internal Medicine and Therapeutics, Clinica Medica II, IRCCS Policlinico San Matteo, University of Pavia, Piazza Golgi 2, 27100, Pavia, Italy
    Eur J Clin Pharmacol 59:271-5. 2003
    ..The aim of this study was to compare the effects of benazepril and amlodipine in monotherapy versus in combination with plasma t-PA and PAI-1 activity in hypertensive type-2 diabetic patients...
  28. ncbi Influence of losartan and atenolol on memory function in very elderly hypertensive patients
    R Fogari
    Department of Internal Medicine and Therapeutics, Clinica Medica II, IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy
    J Hum Hypertens 17:781-5. 2003
    ..05) for both memory tests. These data suggest that in very elderly hypertensive patients, chronic AT1 receptor blockade by losartan could improve cognitive function, in particular immediate and delayed memory...
  29. ncbi Telmisartan and irbesartan therapy in type 2 diabetic patients treated with rosiglitazone: effects on insulin-resistance, leptin and tumor necrosis factor-alpha
    Giuseppe Derosa
    Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy
    Hypertens Res 29:849-56. 2006
    ..These observed metabolic effects of different angiotensin type 1 receptor blockers could be relevant when choosing a therapy to correct metabolic derangement of patients affected by metabolic syndrome and diabetes...
  30. ncbi Metabolic and antihypertensive effects of moxonidine and moxonidine plus irbesartan in patients with type 2 diabetes mellitus and mild hypertension: a sequential, randomized, double-blind clinical trial
    Giuseppe Derosa
    Department o f Internal Medicine and Therapeutics, University of Pavia, Fondazione IRCCS Policlinico S Matteo, Pavia, Italy
    Clin Ther 29:602-10. 2007
    ..The autonomic nervous system plays an important part in the homeostasis of blood pressure (BP), and sympathetic overactivity may contribute to metabolic conditions such as glycemic intolerance or insulin resistance...
  31. ncbi Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial
    Giuseppe Derosa
    Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy
    Clin Ther 27:1383-91. 2005
    ..Based on a literature search, few direct comparisons of different antihyperglycemic treatments on blood pressure have been reported...
  32. ncbi Effect of delapril/manidipine vs olmesartan/ hydrochlorothiazide combination on insulin sensitivity and fibrinogen in obese hypertensive patients
    Roberto Fogari
    Department of Internal Medicine and Therapeutics, Centro per l Ipertensione e la Fisiopatologia Cardiovascolare, University of Pavia, Italy
    Intern Med 47:361-6. 2008
    ..To compare the effect of delapril/manidipine vs olmesartan/hydrochlorothiazide (HCTZ) combination on insulin sensitivity and plasma fibrinogen in obese hypertensive patients...
  33. ncbi Blood pressure control and inflammatory markers in type 2 diabetic patients treated with pioglitazone or rosiglitazone and metformin
    Giuseppe Derosa
    Department of Internal Medicine and Therapeutics, University of Pavia, Fondazione IRCCS Policlinico S Matteo, Pavia, Italy
    Hypertens Res 30:387-94. 2007
    ....
  34. ncbi Role of angiotensin II in plasma PAI-1 changes induced by imidapril or candesartan in hypertensive patients with metabolic syndrome
    Roberto Fogari
    Department of Internal Medicine and Therapeutics, Centro Ipertensione e Fisiopatologia Cardiovascolare, University of Pavia, Pavia, Italy
    Hypertens Res 34:1321-6. 2011
    ..This suggests that the different effect of angiotensin-converting enzyme inhibitors and Ang II blockers on Ang II production has a role in their different influence on fibrinolysis...
  35. ncbi Addition of manidipine improves the antiproteinuric effect of candesartan in hypertensive patients with type II diabetes and microalbuminuria
    Roberto Fogari
    Department of Internal Medicine and Therapeutics, Centro per l Ipertensione e la Fisiopatologia Cardiovascolare, University of Pavia, Pavia, Italy
    Am J Hypertens 20:1092-6. 2007
    ..We sought to compare the effect of manidipine versus hydrochlorothiazide (HCTZ) in addition to candesartan on the urinary albumin excretion rate (UAER) in hypertensive patients with type II diabetes and microalbuminuria...
  36. ncbi Effect of valsartan and ramipril on atrial fibrillation recurrence and P-wave dispersion in hypertensive patients with recurrent symptomatic lone atrial fibrillation
    Roberto Fogari
    Department of Internal Medicine and Therapeutics, Centro per l Ipertensione e la Fisiopatologia Cardiovascolare, University of Pavia, Pavia, Italy
    Am J Hypertens 21:1034-9. 2008
    ..This study compared the effect of antihypertensive treatment with valsartan or ramipril on atrial fibrillation (AF) recurrence, on P-wave dispersion, (PWD) and on serum procollagen type I carboxy terminal peptide (PIP)...
  37. ncbi Comparison of the effects of telmisartan and nifedipine gastrointestinal therapeutic system on blood pressure control, glucose metabolism, and the lipid profile in patients with type 2 diabetes mellitus and mild hypertension: a 12-month, randomized, doubl
    Giuseppe Derosa
    Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy
    Clin Ther 26:1228-36. 2004
    ..Angiotensin receptor blockers (ARBs) provide effective blood pressure control. Whereas none of the ARBs appear to affect glucose homeostasis, some ARBs have been associated with a decrease in cholesterolemia...
  38. ncbi Effect of valsartan or olmesartan addition to amlodipine on ankle edema in hypertensive patients
    Roberto Fogari
    Clinica Medica II, Centro Ipertensione e Fisiopatologia Cardiovascolare, Department of Internal Medicine and Therapeutics, University of Pavia, Italy
    Adv Ther 27:48-55. 2010
    ..The objective of this study was to compare the effect on ankle edema of adding valsartan (V) or olmesartan (O) to amlodipine (A) in the treatment of hypertension...
  39. ncbi Effect of amlodipine-atorvastatin combination on fibrinolysis in hypertensive hypercholesterolemic patients with insulin resistance
    Roberto Fogari
    Department of Internal Medicine and Therapeutics, Clinica Medica II IRCCS Policlinico S.Matteo, University of Pavia, Pavia, Italy
    Am J Hypertens 17:823-7. 2004
    ....
  40. ncbi Comparative evaluation of effect of valsartan/amlodipine and atenolol/amlodipine combinations on atrial fibrillation recurrence in hypertensive patients with type 2 diabetes mellitus
    Roberto Fogari
    Department of Internal Medicine and Therapeutics, Centro per l Ipertensione e la Fisiopatologia Cardiovascolare, University of Pavia, Pavia, Italy
    J Cardiovasc Pharmacol 51:217-22. 2008
    ..Despite similar BP reduction, valsartan/amlodipine combination was more effective in patients treated with amiodarone or propafenone than atenolol/amlodipine in preventing new episodes of AF in hypertensive diabetic patients...
  41. ncbi Effect of aliskiren addition to amlodipine on ankle edema in hypertensive patients: a three-way crossover study
    Roberto Fogari
    Clinica Medica II, University of Pavia, Centro Ipertensione e Fisiopatologia Cardiovascolare, Department of Internal Medicine and Therapeutics, Pavia, Italy
    Expert Opin Pharmacother 12:1351-8. 2011
    ..The aim of this study was to assess the effect of aliskiren and amlopidine on ankle-foot volume (AFV) and pretibial subcutaneous tissue pressure (PSTP)...
  42. ncbi Effects of valsartan versus olmesartan addition to amlodipine/hydrochlorothiazide combination in treating stage 2 hypertensive patients
    Roberto Fogari
    Clinica Medica II, Centro Ipertensione e Fisiopatologia Cardiovascolare, Department of Internal Medicine and Therapeutics, University of Pavia, Piazzale Golgi 19, 27100 Pavia, Italy
    Expert Opin Pharmacother 13:629-36. 2012
    ..The objective of this study was to assess the effects of valsartan or olmesartan addition to dual therapy with amlodipine + hydrochlorothiazide (HCTZ) in the treatment of stage 2 hypertension...
  43. ncbi Effects of losartan and amlodipine alone or combined with simvastatin in hypertensive patients with nonalcoholic hepatic steatosis
    Roberto Fogari
    Department of Internal Medicine and Therapeutics, Centro Ipertensione e Fisiopatologia Cardiovascolare, University of Pavia, Pavia, Italy
    Eur J Gastroenterol Hepatol 24:164-71. 2012
    ....
  44. ncbi Synergistic effect of doxazosin and acarbose in improving metabolic control in patients with impaired glucose tolerance
    Giuseppe Derosa
    Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy
    Clin Drug Investig 26:529-39. 2006
    ..The aim of this study was to evaluate if the expected improvement in glucose and lipid metabolism obtainable with doxazosin is or is not synergistic with standard antihyperglycaemic treatment using the alpha-glucosidase inhibitor acarbose...
  45. ncbi Fibrinolysis and insulin sensitivity in imidapril and candesartan (FISIC study) recipients with hypertension
    Roberto Fogari
    Department of Internal Medicine and Therapeutics, Clinica Medica II, Centro Ipertensione e Fisiopatologia Cardiovascolare, University of Pavia, Pavia, Italy
    Hypertens Res 34:509-15. 2011
    ....
  46. ncbi Thiazolidinedione effects on blood pressure in diabetic patients with metabolic syndrome treated with glimepiride
    Giuseppe Derosa
    Department of Internal Medicine and Therapeutics, University of Pavia, Italy
    Hypertens Res 28:917-24. 2005
    ....
  47. ncbi Effect of body weight loss and normalization on blood pressure in overweight non-obese patients with stage 1 hypertension
    Roberto Fogari
    Department of Internal Medicine and Therapeutics, Centro Ipertensione e Fisiopatologia Cardiovascolare, University of Pavia, Pavia, Italy
    Hypertens Res 33:236-42. 2010
    ..Half of the patients who had normalized BMI also had normalized BP, which could indicate that these patients essentially did not have a form of hypertension but that these effects were instead secondary to being overweight...
  48. ncbi Efficacy and safety of two treatment combinations of hypertension in very elderly patients
    Roberto Fogari
    Department of Internal Medicine and Therapeutics, Centro per l Ipertensione e la Fisiopatologia Cardiovascolare, University of Pavia, Piazzale Golgi 19, I 27100 Pavia, Italy
    Arch Gerontol Geriatr 48:401-5. 2009
    ..However, valsartan/amlodipine offered some advantages in terms of less pronounced BP orthostatic changes and absence of metabolic adverse effects...
  49. ncbi A comparison of the effects of pioglitazone and rosiglitazone combined with glimepiride on prothrombotic state in type 2 diabetic patients with the metabolic syndrome
    Giuseppe Derosa
    Department of Internal Medicine and Therapeutics, University of Pavia, P le C Golgi, 2 27100 Pavia, Italy
    Diabetes Res Clin Pract 69:5-13. 2005
    ..To compare the effects of glimepiride plus pioglitazone or plus rosiglitazone in diabetic patients with the metabolic syndrome on coagulation and fibrinolysis parameters...
  50. ncbi Efficacy and tolerability of candesartan cilexetil/hydrochlorothiazide and amlodipine in patients with poorly controlled mild-to-moderate essential hypertension
    Roberto Fogari
    Department of Internal Medicine and Therapeutics, Centro per l Ipertensione e la Fisiopatologia Cardiovascolare, University of Pavia, Pavia
    J Renin Angiotensin Aldosterone Syst 8:139-44. 2007
    ..Tolerance is an important clinical consideration in the chronic treatment of an asymptomatic disease...
  51. ncbi Effect of telmisartan and ramipril on atrial fibrillation recurrence and severity in hypertensive patients with metabolic syndrome and recurrent symptomatic paroxysmal and persistent atrial fibrillation
    Roberto Fogari
    Department of Internal Medicine and Therapeutics, Centro per l Ipertensione e la Fisiopatologia Cardiovascolare, University of Pavia, Pavia, Italy
    J Cardiovasc Pharmacol Ther 17:34-43. 2012
    ..This could be related to a specific effect of telmisartan on atrial electric remodeling...
  52. ncbi Effect of telmisartan on paroxysmal atrial fibrillation recurrence in hypertensive patients with normal or increased left atrial size
    Roberto Fogari
    Department of Internal Medicine and Therapeutics, Center for Hypertension and Cardiovascular Physiopathology, University of Pavia, Pavia, Italy
    Clin Cardiol 35:359-64. 2012
    ....
  53. ncbi Effects of valsartan or ramipril addition to amlodipine/hydrochlorothiazide combination on left ventricular mass in diabetic hypertensive patients with left ventricular hypertrophy
    Roberto Fogari
    University of Pavia, Clinica Medica II, Centro Ipertensione e Fisiopatologia Cardiovascolare, Department of Internal Medicine and Therapeutics, Fondazione IRCC Policlinico S Matteo, Piazzale Golgi 19, 27100 Pavia, Italy
    Expert Opin Pharmacother 13:1091-9. 2012
    ..The objective of this study was to compare valsartan or ramipril addition to amlodipine + hydrochlorothiazide (HCTZ) on blood pressure (BP) and left ventricular hypertrophy (LVH) in hypertensive diabetic patients with LVH...
  54. ncbi Effect of telmisartan addition to amlodipine on ankle edema development in treating hypertensive patients
    Roberto Fogari
    University of Pavia, Clinica Medica II, Centro Ipertensione e Fisiopatologia Cardiovascolare, Department of Internal Medicine and Therapeutics, Piazzale Golgi 19, 27100 Pavia, Italy
    Expert Opin Pharmacother 12:2441-8. 2011
    ..The objective of this research was to evaluate the effect of telmisartan addition to amlodipine, on peripheral edema in hypertensive patients...
  55. ncbi Effect of valsartan addition to amlodipine on insulin sensitivity in overweight-obese hypertensive patients
    Roberto Fogari
    Department of Internal Medicine and Therapeutics, Centro per l Ipertensione e la Fisiopatologia Cardiovascolare, University of Pavia, Italy
    Intern Med 47:1851-7. 2008
    ..The aim of the study was to evaluate the effect of valsartan/amlodipine combination on insulin sensitivity in overweight-obese hypertensive patients...
  56. ncbi Effect of manidipine as compared to atenolol on platelet aggregation in elderly patients with isolated systolic hypertension and type II diabetes mellitus
    Amedeo Mugellini
    Department of Internal Medicine and Therapeutics, Clinica Medica II, IRCCS Policlinico S Matteo, University of Pavia, Pavia, Italy
    J Cardiovasc Pharmacol 45:310-3. 2005
    ..The clinical impact of this positive effect in terms of prevention of cardiovascular complications in these high-risk patients remains to be clarified...
  57. ncbi A randomized, double-blind, controlled, parallel-group comparison of perindopril and candesartan in hypertensive patients with type 2 diabetes mellitus
    Giuseppe Derosa
    Department of Internal Medicine and Therapeutics, University of Pavia, IRCCS Policlinico S Matteo, Pavia, Italy
    Clin Ther 25:2006-21. 2003
    ....
  58. ncbi Time to achieve blood pressure goal with a combination versus a conventional monotherapy approach in hypertensive patients with metabolic syndrome
    Roberto Fogari
    Department of Internal Medicine and Therapeutics, Centro Ipertensione e Fisiopatologia Cardiovascolare, University of Pavia, Pavia, Italy
    Clin Exp Hypertens 32:245-50. 2010
    ..3%, ns). These results suggest that initial therapy with a V/A combination approach may be more quickly effective than a conventional sequential monotherapy approach in achieving target BP in hypertensive patients with metabolic syndrome...
  59. ncbi Effect of doxazosin on C-reactive protein plasma levels and on nitric oxide in patients with hypertension
    Giuseppe Derosa
    Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy
    J Cardiovasc Pharmacol 47:508-12. 2006
    ..05) in hypertensive patients after antihypertensive treatment. These results suggest that doxazosin treatment exerts anti-inflammatory effects in addition to its antihypertensive properties in hypertensive patients...
  60. ncbi Losartan and perindopril effects on plasma plasminogen activator inhibitor-1 and fibrinogen in hypertensive type 2 diabetic patients
    Roberto Fogari
    Department of Internal Medicine and Therapeutics, IRCCS Policlinico S Matteo, University of Pavia, Italy
    Am J Hypertens 15:316-20. 2002
    ..Different effects of the two drugs on the bradykinin system might also be implicated...
  61. ncbi Effects of doxazosin and irbesartan on blood pressure and metabolic control in patients with type 2 diabetes and hypertension
    Giuseppe Derosa
    Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy
    J Cardiovasc Pharmacol 45:599-604. 2005
    ..In conclusion, both doxazosin and irbesartan reduced BP during long-term treatment, but not to recommended levels, and doxazosin had the more beneficial effect on glucose metabolism and lipid profile...
  62. ncbi Effects of telmisartan compared with eprosartan on blood pressure control, glucose metabolism and lipid profile in hypertensive, type 2 diabetic patients: a randomized, double-blind, placebo-controlled 12-month study
    Giuseppe Derosa
    Department of Internal Medicine and Therapeutics, University of Pavia, Italy
    Hypertens Res 27:457-64. 2004
    ....
  63. ncbi Valsartan addition to amlodipine is more effective than losartan addition in hypertensive patients inadequately controlled by amlodipine
    Roberto Fogari
    Department of Internal Medicine and Therapeutics, Centro Ipertensione e Fisiopatologia Cardiovascolare, University of Pavia, Pavia, Italy
    Vasc Health Risk Manag 6:87-93. 2010
    ..This study evaluated the effects on blood pressure (BP) of valsartan 160 mg or losartan 100 mg addition to amlodipine 5 mg in hypertensive patients...
  64. ncbi Fixed combination of manidipine and delapril in the treatment of mild to moderate essential hypertension: evaluation by 24-hour ambulatory blood pressure monitoring
    Amedeo Mugellini
    Dipartimento di Medicina Interna e Terapia Medica, Clinica Medica II, , IRCCS Policlinico San Matteo, Italy
    Blood Press Suppl 1:6-13. 2005
    ..These results support the use of fixed manidipine-delapril combination in the treatment of mild to moderate hypertensive patients inadequately controlled by monotherapy...
  65. ncbi Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trial
    Amedeo Mugellini
    Department of Internal Medicine and Therapeutics, Clinica Medica II, IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy
    Clin Ther 26:1419-26. 2004
    ....
  66. ncbi Combination of lisinopril and nifedipine GITS increases blood pressure control compared with single drugs in essential hypertensive patients
    Stefano Taddei
    Department of Internal Medicine, University of Pisa, Pisa, Italy
    J Cardiovasc Pharmacol 41:579-85. 2003
    ....
  67. ncbi Comparison of glycaemic control and cardiovascular risk profile in patients with type 2 diabetes during treatment with either repaglinide or metformin
    Giuseppe Derosa
    Department of Internal Medicine and Therapeutics, University of Pavia, IRCCS Policlinico S Matteo, P le C Golgi 2, 27100 Pavia, Italy
    Diabetes Res Clin Pract 60:161-9. 2003
    ..To compare glycaemic control and cardiovascular risk profile in patients with type 2 diabetes following 12 months' treatment with either repaglinide or metformin...
  68. ncbi Randomized, double-blind, placebo-controlled comparison of the action of orlistat, fluvastatin, or both an anthropometric measurements, blood pressure, and lipid profile in obese patients with hypercholesterolemia prescribed a standardized diet
    Giuseppe Derosa
    Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy
    Clin Ther 25:1107-22. 2003
    ....
  69. ncbi Sexual activity and plasma testosterone levels in hypertensive males
    Roberto Fogari
    Department of Internal Medicine and Therapeutics, Clinica Medica, IRCCS Policlinico S. Matteo, University of Pavia, Italy
    Am J Hypertens 15:217-21. 2002
    ..The elucidation of the nature of such a relationship and its physiologic and clinical significance needs further investigation...
  70. ncbi Comparison between repaglinide and glimepiride in patients with type 2 diabetes mellitus: a one-year, randomized, double-blind assessment of metabolic parameters and cardiovascular risk factors
    Giuseppe Derosa
    Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy
    Clin Ther 25:472-84. 2003
    ..Repaglinide and glimepiride are relatively new oral hypoglycemic agents. Few data are available concerning their effects on metabolic parameters other than measures of glycemic control...
  71. ncbi Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension
    Diego Geroldi
    Interdepartmental Center for Research in Molecular Medicine CIRMC, Department of Internal Medicine and Medical Therapeutics, IRCCS San Matteo Hospital, University of Pavia, Piazzale Golgi 2, 27100 Pavia, Italy
    J Hypertens 23:1725-9. 2005
    ..Here we studied the plasma sRAGE levels in hypertensive and normotensive human subjects. We also investigated the relationship between blood pressure parameters and plasma sRAGE concentrations...
  72. ncbi Matrix metalloprotease activity is enhanced in the compensated but not in the decompensated phase of pressure overload hypertrophy
    Rossana Tozzi
    Clinica Medica II, Fondazione IRCCS San Matteo, University of Pavia, Pavia, Italy
    Am J Hypertens 20:663-9. 2007
    ..This study was aimed at investigating the process of cardiac remodeling during the different phases of the transition of POH to HF...
  73. ncbi New class of agents for treatment of hypertension: focus on direct renin inhibition
    Roberto Fogari
    Department of Internal Medicine and Therapeutics, University of Pavia, Italy
    Vasc Health Risk Manag 6:869-82. 2010
    ....
  74. ncbi The effect of L-carnitine on plasma lipoprotein(a) levels in hypercholesterolemic patients with type 2 diabetes mellitus
    Giuseppe Derosa
    Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy
    Clin Ther 25:1429-39. 2003
    ..A previous study has demonstrated that L-carnitine reduces plasma lipoprotein(a) (Lp[a]) levels in patients with hypercholesterolemia...
  75. ncbi Association between low-molecular weight apolipoprotein(a) isoforms and obesity in Italian women
    Giuseppe Derosa
    Department of Internal Medicine and Therapeutics, Section of Internal Medicine, Vascular and Metabolic Diseases, Istituto di Ricovero e Cura a Carattere Scientifico Policlinico San Matteo, University of Pavia, P le C Golgi, Italy
    Obes Res 12:1322-6. 2004
    ..The hypothesis of this study was to assess whether there are differences in the distribution of apo(a) phenotypes between obese patients and healthy controls...
  76. ncbi Dynamic interactions between musical, cardiovascular, and cerebral rhythms in humans
    Luciano Bernardi
    Department of Internal Medicine, Pavia University and IRCCS S Matteo, Pavia, Italy
    Circulation 119:3171-80. 2009
    ..We tested whether compositions characterized by variable emphasis could produce parallel instantaneous cardiovascular/respiratory responses and whether these changes mirrored music profiles...
  77. ncbi Sympathectomy or doxazosin, but not propranolol, blunt myocardial interstitial fibrosis in pressure-overload hypertrophy
    Stefano Perlini
    Clinica Medica II, IRCCS San Matteo, , Italy
    Hypertension 46:1213-8. 2005
    ..Thus in the course of experimental pressure overload, the sympathetic nervous system plays a major pro-fibrotic role, which is mediated via alpha-adrenergic but not beta-adrenergic receptors...
  78. ncbi Matrix metalloproteinase 2 may be a marker of microangiopathy in children and adolescents with type 1 diabetes mellitus
    Giuseppe Derosa
    Department of Internal Medicine and Therapeutics, University of Pavia, P le C Golgi 2, 27100 Pavia, Italy
    Diabetes Res Clin Pract 70:119-25. 2005
    ..It is well known that MMP-9 is an index of the severity and stability of macroangiopathy while our results allow us to postulate that MMP-2 may be a marker of microangiopathy...
  79. ncbi Efficacy of manidipine/delapril versus losartan/hydrochlorothiazide fixed combinations in patients with hypertension and diabetes
    Alejandro Roca-Cusachs
    Santa Creu i Sant Pau Hospital, Barcelona, Spain
    J Hypertens 26:813-8. 2008
    ..Less than one in eight patients with hypertension and type 2 diabetes have adequately controlled blood pressure. As a result, antihypertensive combinations are now widely used in management of hypertension associated with diabetes...
  80. ncbi Circulating amyloidogenic free light chains and serum N-terminal natriuretic peptide type B decrease simultaneously in association with improvement of survival in AL
    Giovanni Palladini
    Biotechnology Research Laboratories-IRCCS Policlinico San Matteo, Piazzale Golgi 19, 27100-Pavia, Italy
    Blood 107:3854-8. 2006
    ..Cardiac function in AL can rapidly improve due to a reduction of the circulating amyloidogenic precursor, despite the amount of cardiac amyloid deposits remaining apparently unaltered, as measured by echocardiography...
  81. ncbi Matrix metalloproteinase 2 may be a marker of microangiopathy in children and adolescents with type 1 diabetes
    Giuseppe Derosa
    Diabetes Care 27:273-4. 2004